Aberdeen Group’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-360,374
| Closed | -$13.6M | – | 918 |
|
|
2019
Q4 | $13.6M | Buy |
360,374
+5,580
| +2% | +$210K | 0.03% | 399 |
|
|
2019
Q3 | $16.5M | Buy |
354,794
+1,808
| +0.5% | +$84.3K | 0.04% | 355 |
|
|
2019
Q2 | $18.5M | Buy |
352,986
+339,711
| +2,559% | +$17.8M | 0.04% | 377 |
|
|
2019
Q1 | $915K | Hold |
13,275
| – | – | ﹤0.01% | 817 |
|
|
2018
Q4 | $790K | Buy |
13,275
+3,775
| +40% | +$225K | ﹤0.01% | 782 |
|
|
2018
Q3 | $1.1M | Buy |
9,500
+2,025
| +27% | +$234K | ﹤0.01% | 791 |
|
|
2018
Q2 | $943K | Sell |
7,475
-76
| -1% | -$9.59K | ﹤0.01% | 802 |
|
|
2018
Q1 | $817K | Hold |
7,551
| – | – | ﹤0.01% | 749 |
|
|
2017
Q4 | $827K | Buy |
7,551
+1,100
| +17% | +$120K | ﹤0.01% | 745 |
|
|
2017
Q3 | $637K | Buy |
+6,451
| New | +$637K | ﹤0.01% | 744 |
|